ORGS - undecided hereIf it breaks the trend line at 5, we may see resistance test at 6.1 again.
If 5 is not broken, then back to 4.4 support testing.
Looks like 4.4 should not be broken so sooner or later we will see 6.
−0.8994USD
−14.89 MUSD
36.03 MUSD
28.66 M
About Orgenesis Inc.
Sector
Industry
CEO
Vered Caplan
Website
Headquarters
Germantown
Employees (FY)
167
Founded
2008
ISIN
US68619K2042
FIGI
BBG000PPPSF1
Orgenesis, Inc. is a biotechnology company, which engages in the development, manufacturing, and provision of technologies, and services in the cell and gene therapy industry. It operates through the Morgenesis and Therapies segments. The Morgenesis segment refers to the POCare services. The Therapies segment is involved in therapeutic development operations. The company was founded by Sarah Ferber on June 5, 2008 and is headquartered in Germantown, MD.
BUY ORGS - ORGENESIS INC - STRONG BUY ON WEEKLY CHARTBUY ORGS - ORGENESIS INC - STRONG BUY ON WEEKLY CHART
Orgenesis Inc (ORGS)ORGS carving out a nice wedge here after a multi-month pullback. Yesterday’s price action produced an almost perfect bullish reversal Dragonfly Doji, which is just about to kiss the underside of the wedge resistance line and 50 DMA. Plenty of recent Insider buying activity going on, with short inter
Orgenesis Announces Stock Repurchase Plan of Up to $10 Million!!ORGS: Orgenesis Inc.
2020-05-15 07:30:10
Orgenesis Announces Stock Repurchase Plan of Up to $10 Million
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ORGS is 0.50 USD — it has increased by 1.36% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Orgenesis Inc. stocks are traded under the ticker ORGS.
Orgenesis Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
ORGS earnings for the last quarter are −0.43 USD whereas the estimation was 0.10 USD which accounts for −530.00% surprise. Estimated earnings for the next quarter are −1.16 USD. See more details about Orgenesis Inc. earnings.
Orgenesis Inc. revenue for the last quarter amounts to 110.00 K USD despite the estimated figure of 13.50 M USD. In the next quarter revenue is expected to reach −13.59 M USD.
Yes, you can track Orgenesis Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, ORGS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Orgenesis Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 167.00 employees. See our rating of the largest employees — is Orgenesis Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Orgenesis Inc. EBITDA is −6.45 M USD, and current EBITDA margin is −15.44%. See more stats in Orgenesis Inc. financial statements.